Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately ...

The North American Nucleic Acid Amplification Testing (NAAT) market will reach $7.64 billion by 2033, growing from $3.28 ...

If you are also suffering from a bacterial infection and have waited long enough for its natural recovery you may need a Swab ...

AI and computational modeling are reducing reliance on animal testing by simulating human biology, improving drug safety and efficacy predictions. Regulatory bodies like the FDA and NIH are endorsing ...

Researchers from Indiana University Health and the IU School of Medicine have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Thermo Fisher launches a first-of-its-kind qPCR assay detecting key beverage spoilage organisms faster to improve quality and ...

Lyme disease has been on the rise in the United States over the past 30 years, which underscores the need for faster, more ...

Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced that Palmetto GBA, the Medicare Administrative Contractor that administers the Molecular ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...